Showing 1 - 16 results of 16 for search 'Luis F López-Cortés', query time: 0.07s Refine Results
  1. 1
    High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance

    High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance by Karin Neukam, Yusnelkis Milanés Guisado, María Fontillón, Laura Merino, César Sotomayor, Nuria Espinosa, Luis F. López-Cortés, Pompeyo Viciana

    Published 2019-06-01
    Get full text
    Article
  2. 2
    <em>Enterococcus faecalis</em> Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives

    <em>Enterococcus faecalis</em> Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives by Laura Herrera-Hidalgo, Arístides de Alarcón, Luis E. López-Cortes, Rafael Luque-Márquez, Luis F. López-Cortes, Alicia Gutiérrez-Valencia, María V. Gil-Navarro

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life

    Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life by Marta Mejías-Trueba, Alicia Gutierrez-Valencia, Silvia Llaves-Flores, Cristina Roca-Oporto, Marta Herrero, César Sotomayor de la Piedra, Luis F. Lopez-Cortes, Nuria Espinosa

    Published 2024-08-01
    Get full text
    Article
  4. 4
    Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.

    Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. by Juan Macías, Luis F López-Cortés, Francisco Téllez, Eva Recio, Guillermo Ojeda-Burgos, Maria José Ríos, Antonio Rivero-Juárez, Marcial Delgado, Rivas-Jeremías, Juan A Pineda

    Published 2015-01-01
    Get full text
    Article
  5. 5
    Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.

    Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients. by Antonio Rivero-Juárez, Luis F Lopez-Cortes, Angela Camacho, Almudena Torres-Cornejo, Juan A Pineda, Manuel Marquez-Solero, Antonio Caruz, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Alicia Gutierrez-Valencia, Antonio Rivero

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV

    Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV by Marta Mejías-Trueba, Marta Mejías-Trueba, Abraham Saborido-Alconchel, Ana Serna-Gallego, María Trujillo-Rodríguez, Esperanza Muñoz-Muela, Silvia Llaves-Flores, Nuria Espinosa, Cristina Roca-Oporto, Marta Herrero, Cesar Sotomayor, Luis F. López-Cortes

    Published 2024-08-01
    Get full text
    Article
  7. 7
    HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1Research in context

    HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1Research in context by Esperanza Muñoz-Muela, María Trujillo-Rodríguez, Ana Serna-Gallego, Abraham Saborido-Alconchel, Carmen Gasca-Capote, Ana Álvarez-Ríos, Ezequiel Ruiz-Mateos, Dmitri Sviridov, Andrew J. Murphy, Man K.S. Lee, Luis F. López-Cortés, Alicia Gutiérrez-Valencia

    Published 2024-10-01
    Get full text
    Article
  8. 8
    Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered

    Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered by Luis F. López-Cortés, Abraham Saborido-Alconchel, María Trujillo-Rodríguez, Ana Serna-Gallego, Silvia Llaves-Flores, Esperanza Muñoz-Muela, María Jesús Pérez-Santos, Carmen Lozano, Marta Mejias-Trueba, Marta Mejias-Trueba, Cristina Roca, Nuria Espinosa, Alicia Gutiérrez-Valencia

    Published 2023-03-01
    Get full text
    Article
  9. 9
    Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

    Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial by María Trujillo‐Rodríguez, Pompeyo Viciana, Inmaculada Rivas‐Jeremías, Ana I. Álvarez‐Ríos, Antonio Ruiz‐García, Olga Espinosa‐Ibáñez, Salvador Arias‐Santiago, Juliana Martínez‐Atienza, Rosario Mata, Olga Fernández‐López, Ezequiel Ruiz‐Mateos, Alicia Gutiérrez‐Valencia, Luis F. López‐Cortés

    Published 2021-04-01
    Get full text
    Article
  10. 10
    Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors

    Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors by Abraham Saborido-Alconchel, Ana Serna-Gallego, María Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana I. Álvarez-Ríos, Carmen Lozano, Silvia Llaves-Flores, Nuria Espinosa, Cristina Roca-Oporto, Marta Herrero, Cesar Sotomayor, Alicia Gutierrez-Valencia, Alicia Gutierrez-Valencia, Luis F. Lopez-Cortes

    Published 2024-07-01
    Get full text
    Article
  11. 11
    Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients.

    Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients. by Luis F López-Cortés, Rosa Ruiz-Valderas, Luis Jimenez-Jimenez, María F González-Escribano, Almudena Torres-Cornejo, Rosario Mata, Antonio Rivero, Juan A Pineda, Manuel Marquez-Solero, Pompeyo Viciana, Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas

    Published 2012-01-01
    Get full text
    Article
  12. 12
    Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

    Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. by Karin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, Thomas Lutz, Jan Fehr, Mattias Mandorfer, Sanjay Bhagani, Luis F López-Cortés, Annette Haberl, Marcel Stoeckle, Manuel Márquez, Stefan Scholten, Ignacio de Los Santos-Gil, Stefan Mauss, Antonio Rivero, Antonio Collado, Marcial Delgado, Juergen K Rockstroh, Juan A Pineda

    Published 2015-01-01
    Get full text
    Article
  13. 13
    Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.

    Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population. by Luis F López-Cortés, Pompeyo Viciana, José A Girón-González, Alberto Romero-Palacios, Manuel Márquez-Solero, Maria A Martinez-Perez, Miguel A López-Ruz, Javier de la Torre-Lima, Francisco Téllez-Pérez, Marcial Delgado-Fernández, Milagros Garcia-Lázaro, Fernando Lozano, Mohamed O Mohamed-Balghata, Sociedad Andaluza de Enfermedades Infecciosas

    Published 2014-01-01
    Get full text
    Article
  14. 14
    Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

    Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes by Laia Reverté, Elena Yeregui, Montserrat Olona, Alicia Gutiérrez‐Valencia, Maria José Buzón, Anna Martí, Frederic Gómez‐Bertomeu, Teresa Auguet, Luis F. López‐Cortés, Joaquin Burgos, Clara Benavent‐Bofill, Carme Boqué, Graciano García‐Pardo, Ezequiel Ruiz‐Mateos, Maria Teresa Mestre, Francesc Vidal, Consuelo Viladés, Joaquim Peraire, Anna Rull, COVIDOMICS Study Group

    Published 2022-01-01
    Get full text
    Article
  15. 15
    Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypesResearch in context

    Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypesResearch in context by Maria R. Jimenez-Leon, Carmen Gasca-Capote, Laura Tarancon-Diez, Beatriz Dominguez-Molina, Macarena Lopez-Verdugo, Ryan Ritraj, Isabel Gallego, Ana I. Alvarez-Rios, Joana Vitalle, Sara Bachiller, María Inés Camacho-Sojo, Alberto Perez-Gomez, Nuria Espinosa, Cristina Roca-Oporto, Mohamed Rafii-El-Idrissi Benhnia, Alicia Gutierrez-Valencia, Luis F. Lopez-Cortes, Ezequiel Ruiz-Mateos

    Published 2023-05-01
    Get full text
    Article
  16. 16
    Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response

    Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response by Alberto Pérez‐Gómez, Carmen Gasca‐Capote, Joana Vitallé, Francisco J. Ostos, Ana Serna‐Gallego, María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Teresa Giráldez‐Pérez, Julia Praena‐Segovia, María D. Navarro‐Amuedo, María Paniagua‐García, Manuel García‐Gutiérrez, Manuela Aguilar‐Guisado, Inmaculada Rivas‐Jeremías, María Reyes Jiménez‐León, Sara Bachiller, Alberto Fernández‐Villar, Alexandre Pérez‐González, Alicia Gutiérrez‐Valencia, Mohammed Rafii‐El‐Idrissi Benhnia, Daniela Weiskopf, Alessandro Sette, Luis F. López‐Cortés, Eva Poveda, Ezequiel Ruiz‐Mateos, Virgen del Rocío Hospital COVID‐19 and COHVID‐GS Working Teams

    Published 2022-04-01
    Get full text
    Article

Search Tools: